NOCIL Limited has issued a formal communication to shareholders regarding the availability of Tax Deduction at Source (TDS) certificates for dividend payments made during FY 2024-25. The company has provided detailed instructions for shareholders to access and download their certificates through the designated online portal.

Dividend Payment Details

The company paid dividends to all shareholders from August 14th, 2025, following the declaration at the 63rd Annual General Meeting held on Thursday, August 7th, 2025. As per the Income-tax Act, 1961, as amended by the Finance Act, 2020, NOCIL deducted TDS at prevailing rates from dividend payments.

TDS Deduction Criteria

The company deducted TDS only from shareholders whose dividend income exceeded the threshold limit and who did not provide valid exemption forms. The TDS certificates are being provided in Form No. 16A as required under tax regulations.

Certificate Download Process

Shareholders can access their TDS certificates through KFin Technologies Limited's online portal. The download process involves:

• Visit the URL: https://ris.kfintech.com/clientservices/tds
• Validate login using Income Tax Permanent Account Number (PAN)
• Enter DP ID/Client ID or Physical Folio details
• Download the certificate directly from the portal

Support and Contact Information

For assistance with downloading TDS certificates, shareholders can contact KFin Technologies Limited. The certificates will remain available on the website for one year, after which shareholders must request copies directly from the registrar.

Additional Information

Shareholders can also view TDS credits in Form 26AS and download it from their e-filing account at the Income Tax Department's portal. The communication was signed by Amit K. Vyas, Head (Legal) & Company Secretary, and has been filed with both BSE and NSE for regulatory compliance.

NOCIL Limited conducted its Q3FY26 earnings conference call on February 12, 2026, where management provided detailed insights into the company's operational performance and future growth prospects. The call, led by Managing Director V.S. Anand and CFO P. Srinivasan, addressed investor queries about the quarter's performance and strategic initiatives.

Q3FY26 Financial Performance Overview

The company reported mixed quarterly results with revenue remaining largely stable at ₹316 crores. Management highlighted that domestic volumes witnessed high single-digit growth driven by improved demand due to GST 2.0 implementation, while international volumes were dampened by seasonal effects and US tariff issues.

Volume Performance and Market Dynamics

During the earnings call, management revealed that sales volumes for Q3FY26 stood at 140 basis points, taking Q1FY20 as the base of 100. The domestic market showed strong momentum with high single-digit growth year-on-year, while export volumes declined sequentially due to US tariff uncertainties and seasonal factors.

Management expects to end FY26 with volume growth of 3% to 4% despite a 5% degrowth in H1FY26. The US market volumes were particularly affected, operating at approximately 50% of pre-tariff levels during Q3FY26.

Strategic Initiatives and Future Outlook

The company's TDQ antioxidant investment at Dahej is progressing ahead of schedule, with production trials planned during the first half of calendar year 2026. This expansion represents a 20% increase in overall capacity and is expected to contribute significantly to future growth.

Antidumping Measures and Competitive Landscape

Management provided updates on antidumping petitions filed against select key products with the Government of India. The authorities have initiated detailed investigations across four product notifications covering various countries including China, EU, USA, Korea, and Thailand. The company expects outcomes within the next 1.5 to 2 months following administrative delays due to organizational restructuring.

P. Srinivasan clarified that antidumping duties apply to the country of origin, not the country of supply, preventing potential rerouting strategies. The company has filed cases against both Chinese and Korean players in the antioxidants segment.

Cost Management and Operational Efficiency

The company achieved significant cost savings during the nine-month period, with management highlighting ₹23 crores in conversion cost savings compared to the previous year. These savings resulted from conscious working capital management, production alignment with inventory adjustments, utility optimization, and freight rate negotiations.

Market Recovery and Growth Projections

Looking ahead to FY27, management expressed optimism about volume growth prospects. The resolution of US tariff issues is expected to restore lost volumes within 2-3 months, while the domestic market momentum is anticipated to continue. Management projects double-digit export volume growth for FY27, with the domestic market maintaining its strong performance.

The Indian rubber chemicals market size is estimated at approximately 85,000 tons, with NOCIL holding a 40% market share. The company expects new product contributions to reach 10-12% of current volumes by FY28-FY29, following customer approval processes.

Recognition and Industry Partnerships

During the quarter, NOCIL received the CII Industry Academia Partnership Award 2025 in the diamond category from the Confederation of Indian Industry. This recognition acknowledges the company's collaborative work and sponsored projects with research and academic institutions, demonstrating its commitment to innovation and excellence.